KARD
Kardigan, Inc.
There isn't enough reported data to score KARD yet.
KARD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate KARD's fundamentals.
KARD PE Valuation
KARD has no meaningful PE right now: it lost money over the past year.
KARD Forward outlook
There aren't enough analyst estimates for KARD to show an outlook.
KARD Earnings Per Share
KARD Quarterly Revenue
KARD Free Cash Flow
KARD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +265% | +66.9M shares |
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
KARD Net Leverage
KARD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KARD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 21.7 | Neutral |
KARD's weekly RSI is 52 (neutral) and its Stochastic is 22 (neutral).
KARD PE vs Healthcare Sector
KARD has no meaningful PE right now: it lost money over the past year.
KARD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.2 | 0.8% below |
| 20 week MA | $18.2 | 22% below |
KARD is in a downtrend: it's below all two of its weekly moving averages, and 22% below its 20-week average.
KARD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $22.0 | $14.1 | -36% |
It's down 36% so far in 2026.